102 related articles for article (PubMed ID: 22581080)
1. Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat.
Huang HQ; Tang J; Zhou ST; Yi T; Peng HL; Shen GB; Xie N; Huang K; Yang T; Wu JH; Huang CH; Wei YQ; Zhao X
Int J Oncol; 2012 Aug; 41(2):523-32. PubMed ID: 22581080
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.
Tong A; Zhang H; Li Z; Gou L; Wang Z; Wei H; Tang M; Liang S; Chen L; Huang C; Wei Y
Cancer Chemother Pharmacol; 2008 Apr; 61(5):791-802. PubMed ID: 17593366
[TBL] [Abstract][Full Text] [Related]
3. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
4. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
[TBL] [Abstract][Full Text] [Related]
5. Activity-based proteome profiling of potential cellular targets of Orlistat--an FDA-approved drug with anti-tumor activities.
Yang PY; Liu K; Ngai MH; Lear MJ; Wenk MR; Yao SQ
J Am Chem Soc; 2010 Jan; 132(2):656-66. PubMed ID: 20028024
[TBL] [Abstract][Full Text] [Related]
6. Depletion of PKM2 leads to impaired glycolysis and cell death in 2-demethoxy-2,3-ethylenediamino hypocrellin B-photoinduced A549 cells.
Zhou Z; Liu Y; Qin M; Sheng W; Wang X; Li Z; Zhong R
J Photochem Photobiol B; 2014 May; 134():1-8. PubMed ID: 24792468
[TBL] [Abstract][Full Text] [Related]
7. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].
Zhang XP; Xiao ZQ; Chen ZC; Li C; Li JL; Yu YH; Ouyang YM; Feng XP; Zhang PF
Ai Zheng; 2006 Jan; 25(1):22-8. PubMed ID: 16405744
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of paclitaxel-resistance associated hnRNP A2 and GDI 2 proteins in human ovarian cancer cells.
Lee DH; Chung K; Song JA; Kim TH; Kang H; Huh JH; Jung SG; Ko JJ; An HJ
J Proteome Res; 2010 Nov; 9(11):5668-76. PubMed ID: 20858016
[TBL] [Abstract][Full Text] [Related]
10. Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines.
Yan XD; Pan LY; Yuan Y; Lang JH; Mao N
J Proteome Res; 2007 Feb; 6(2):772-80. PubMed ID: 17269733
[TBL] [Abstract][Full Text] [Related]
11. Chemical modification and organelle-specific localization of orlistat-like natural-product-based probes.
Yang PY; Liu K; Zhang C; Chen GY; Shen Y; Ngai MH; Lear MJ; Yao SQ
Chem Asian J; 2011 Oct; 6(10):2762-75. PubMed ID: 21744505
[TBL] [Abstract][Full Text] [Related]
12. CHM-1 induces apoptosis via p38-mediated upregulation of DR5 expression in human ovarian cancer SKOV3 cells.
Lee JC; Chou LC; Huang CH; Chung JG; Huang LJ; Lee KH; Hung MC; Way TD; Kuo SC
Eur J Pharmacol; 2011 Nov; 670(1):96-104. PubMed ID: 21907193
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal.
Chuang HY; Chang YF; Hwang JJ
Biomed Pharmacother; 2011 Jul; 65(4):286-92. PubMed ID: 21723078
[TBL] [Abstract][Full Text] [Related]
14. Differential proteomic profiling identifies novel molecular targets of paclitaxel and phytoagent deoxyelephantopin against mammary adenocarcinoma cells.
Lee WL; Wen TN; Shiau JY; Shyur LF
J Proteome Res; 2010 Jan; 9(1):237-53. PubMed ID: 19894775
[TBL] [Abstract][Full Text] [Related]
15. Gossypol induces apoptosis in ovarian cancer cells through oxidative stress.
Wang J; Jin L; Li X; Deng H; Chen Y; Lian Q; Ge R; Deng H
Mol Biosyst; 2013 Jun; 9(6):1489-97. PubMed ID: 23532321
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells.
Chen G; Li A; Zhao M; Gao Y; Zhou T; Xu Y; Du Z; Zhang X; Yu X
J Proteome Res; 2008 Jul; 7(7):2733-42. PubMed ID: 18549279
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism study of antisense cyclin B1 in tumorigenesis inhibition using proteomic technique].
Yang T; Zhang L; Yan F; Tong AP; Liu XY; Liu HY; Huang CH
Ai Zheng; 2007 Mar; 26(3):264-9. PubMed ID: 17355788
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines.
Dai Z; Yin J; He H; Li W; Hou C; Qian X; Mao N; Pan L
Proteomics; 2010 Nov; 10(21):3789-99. PubMed ID: 20957754
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of cervical cancer cells treated with suberonylanilide hydroxamic acid.
He J; Huang C; Tong A; Chen B; Zeng Z; Zhang P; Wang C; Wei Y
J Biosci; 2008 Dec; 33(5):715-21. PubMed ID: 19179759
[TBL] [Abstract][Full Text] [Related]
20. Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells.
Pan TL; Hung YC; Wang PW; Chen ST; Hsu TK; Sintupisut N; Cheng CS; Lyu PC
Proteomics; 2010 Mar; 10(5):914-29. PubMed ID: 20049856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]